Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer

Overview of attention for article published in EJNMMI Research, November 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#25 of 603)
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

patent: 9 patents

Readers on

mendeley: 148 Mendeley

Summary Patents

So far, Altmetric has seen 9 patents that reference this research output.

Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy

Grant US-11911488-B2

United States of America

SILICON-BASED FLUORIDE ACCEPTOR GROUPS FOR RADIOPHARMACEUTICALS

Application WO-2024023332-A1

World Intellectual Property Organisation (WIPO)

PSMA LIGANDS FOR IMAGING AND ENDORADIOTHERAPY

N/A RU-2807076-C2

Russian Federation

Prostate-specific membrane antigen targeted high-affinity agents for endoradiotherapy of…

Grant US-11458213-B2

United States of America

CXCR4-LIGANDS FOR DIAGNOSTIC AND THERAPEUTIC USE AND PRECURSORS THEREOF

Application EP-4043041-A1

European Patent Office

SILICON-CONTAINING LIGAND COMPOUNDS

Application WO-2022018264-A1

World Intellectual Property Organisation (WIPO)

PROSTATE-SPECIFIC MEMBRANE ANTIGEN TARGETED HIGH-AFFINITY AGENTS FOR ENDORADIOTHERAPY OF…

Application EP-3925952-A1

European Patent Office

Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy

Grant US-10736974-B2

United States of America

Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and therapy

Grant US-10688200-B2

United States of America